S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(1.45%) $922.85
USD/EUR
(0.01%) $0.927
USD/NOK
(0.13%) $10.86
USD/GBP
(0.02%) $0.792
USD/RUB
(0.12%) $92.55

Realtime updates for Sana Biotechnology, Inc. [SANA]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
44.44%
return 16.75%
SELL
44.44%
return -3.46%
Last Updated28 Mar 2024 @ 16:00

0.00% $ 10.00

BUY 62127 min ago

@ $7.22

Issued: 14 Feb 2024 @ 15:45


Return: 38.60%


Previous signal: Feb 13 - 14:34


Previous signal: Sell


Return: 12.56 %

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302
Profile picture for Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Stats
Today's Volume 1.23M
Average Volume 3.51M
Market Cap 2.20B
EPS $0 ( 2024-03-21 )
Next earnings date ( $-0.300 ) 2024-05-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -6.85
ATR14 $0.0110 (0.11%)
Insider Trading
Date Person Action Amount type
2024-03-08 Yang Patrick Y Sell 25 000 Common Stock
2024-03-07 Williams Douglas E Buy 301 875 Stock Option (Right to Buy)
2024-03-07 Williams Douglas E Buy 67 083 Restricted Stock Units
2024-03-07 Harr Steve Buy 900 000 Stock Option (Right to Buy)
2024-03-07 Harr Steve Buy 200 000 Restricted Stock Units
INSIDER POWER
6.01
Last 98 transactions
Buy: 15 453 136 | Sell: 12 042 863

Volume Correlation

Long: -0.24 (neutral)
Short: -0.94 (very strong negative)
Signal:(45.917) Neutral

Sana Biotechnology, Inc. Correlation

10 Most Positive Correlations
ALVR0.839
MDVL0.839
TCRT0.836
USEG0.834
HOOK0.832
TLSA0.832
GRAY0.828
INFI0.824
OPK0.815
RUBY0.815
10 Most Negative Correlations
BNIXU-0.875
MICT-0.812

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sana Biotechnology, Inc. Correlation - Currency/Commodity

The country flag 0.35
( neutral )
The country flag 0.74
( moderate )
The country flag 0.00
( neutral )
The country flag 0.72
( moderate )
The country flag -0.56
( weak negative )
The country flag -0.05
( neutral )

Sana Biotechnology, Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $-30.87M (0.00 %)
EPS: $-1.460
Q4 2023
Revenue: $0
Gross Profit: $-7.54M (0.00 %)
EPS: $-0.450
Q3 2023
Revenue: $0
Gross Profit: $-4.50M (0.00 %)
EPS: $0.00500
Q2 2023
Revenue: $0
Gross Profit: $-7.85M (0.00 %)
EPS: $-0.590

Financial Reports:

No articles found.

Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that target CD19+ cancer cells, including non-Hodgkin Lymphoma, chronic lymphocytic leukemia, and acute lymphoblastic leukemia; SG221 and SG239 for the treatment of multiple myeloma; and SG328 for ornithine transcarbamylase deficiency. It also develops SG418 for sickle cell disease and beta-thalassemia; SC291, a CD19 allogeneic T cell therapy; SC255 for multiple myeloma; SC451 for type I diabetes mellitus; and SC379 for secondary progressive multiple sclerosis, Pelizaeus-Merzbacher disease, and Huntington's disease. Sana Biotechnology, Inc. was formerly known as FD Therapeutics, Inc. and changed its name to Sana Biotechnology, Inc. in September 2018. The company was incorporated in 2018 and is headquartered in Seattle, Washington.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators